Komori
Other Disclosures3627TECMIRA HOLDINGS INC.Information and Communications, Services and Others

Wellmira and Arteryex Demonstrate the Effectiveness of Multidisciplinary Collaboration Using PHRs

Wellmira and Arteryex conducted an approximately 3-week pilot at a nursing care facility using a system that centrally manages medical, vital-sign, dietary and lifestyle data, confirming that it can support physicians in understanding users’ conditions and making early-intervention decisions, as well as facilitate information sharing among multidisciplinary professionals. The companies will consider expanding integration between their respective apps and increasing the scale of the validation study.

Worth reading
65In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
3
Weekly
Wording
Conditional
How definitive the wording is.

Announced details

支えるノート for 介護 (caregiving support app)パシャっとカルテ (medical records app)Karomama Plus (AI health app)
Applicable field (uses covered by this announcement)
Nursing CareHealthcareMultidisciplinary collaborationDecision support for physiciansPrevention of disease progression
Launch dateConducted from 13 January 2026 (pilot launch; actual results)
What the company reported numerically
Quantitative Effects

Pilot period: approximately 3 weeks

Relationship between the counterparty and the company
TECMIRA HOLDINGS INC.3627
Relationship with the Company

Wellmira and Arteryex are the pilot project participants. Wellmira provides カロママ プラス, while Arteryex provides 支えるノート for 介護 and パシャっとカルテ.

CounterpartyWellmira Co., Ltd.Arteryex Co., Ltd.株式会社とやまかいご

Wellmira: Headquartered in Chiyoda-ku, Tokyo; President and CEO Watanabe Toshinari (渡辺敏成); provides AI-powered health apps and related services. Arteryex: Headquartered in Chiyoda-ku, Tokyo; Representative Director Li Dongying (李東瀛); provides medical information management apps and related services. 株式会社とやまかいご: Operates nursing care facilities.

Location (as indicated in this announcement)

Nursing care facility operated by 株式会社とやまかいご (location undisclosed)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Ministry of Economy, Trade and Industry, “FY2025 Project to Advance the Healthcare Industry Infrastructure (Empirical Research Project for Creating Use Cases for Multidisciplinary Collaboration Using PHRs)”

Announced details
ItemDetails
Names of Products / Services Covered支えるノート for 介護 (caregiving support app), パシャっとカルテ (medical records app), Karomama Plus (AI health app)
CounterpartyWellmira Co., Ltd., Arteryex Co., Ltd., 株式会社とやまかいご
Counterparty overviewWellmira: Headquartered in Chiyoda-ku, Tokyo; President and CEO Watanabe Toshinari (渡辺敏成); provides AI-powered health apps and related services. Arteryex: Headquartered in Chiyoda-ku, Tokyo; Representative Director Li Dongying (李東瀛); provides medical information management apps and related services. 株式会社とやまかいご: Operates nursing care facilities.
Relationship with the CompanyWellmira and Arteryex are the pilot project participants. Wellmira provides カロママ プラス, while Arteryex provides 支えるノート for 介護 and パシャっとカルテ.
Launch dateConducted from 13 January 2026 (pilot launch; actual results)
Applicable areaNursing Care, Healthcare, Multidisciplinary collaboration, Decision support for physicians, Prevention of disease progression
LocationNursing care facility operated by 株式会社とやまかいご (location undisclosed)
Quantitative EffectsPilot period: approximately 3 weeks
SourceMinistry of Economy, Trade and Industry, “FY2025 Project to Advance the Healthcare Industry Infrastructure (Empirical Research Project for Creating Use Cases for Multidisciplinary Collaboration Using PHRs)”
Items this document does not state (9)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The companies established an environment in which medical and lifestyle data could be viewed centrally through PHRs, thereby supporting physicians in understanding users’ conditions and making early-intervention decisions, as well as facilitating information sharing among multidisciplinary professionals.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Wellmira and Arteryex Demonstrate the Effectiveness of Multidisciplinary Collaboration Using PHRs | TECMIRA HOLDINGS INC. (3627) timely disclosure | Komori